BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24563252)

  • 1. Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy.
    Viney JM; Andrew DP; Phillips RM; Meiser A; Patel P; Lennartz-Walker M; Cousins DJ; Barton NP; Hall DA; Pease JE
    J Immunol; 2014 Apr; 192(7):3419-27. PubMed ID: 24563252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL22-specific Antibodies Reveal That Engagement of Two Distinct Binding Domains on CCL22 Is Required for CCR4-mediated Function.
    Santulli-Marotto S; Wheeler J; Lacy ER; Boakye K; Luongo J; Wu SJ; Ryan M
    Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):373-80. PubMed ID: 26683175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surrogate antibodies that specifically bind and neutralize CCL17 but not CCL22.
    Santulli-Marotto S; Fisher J; Petley T; Boakye K; Panavas T; Luongo J; Kavalkovich K; Rycyzyn M; Wu B; Gutshall L; Coelho A; Hogaboam CM; Ryan M
    Monoclon Antib Immunodiagn Immunother; 2013 Jun; 32(3):162-71. PubMed ID: 23750473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of chemokine receptor CCR4 and its ligands (CCL17 and CCL22) in murine contact hypersensitivity.
    Kusumoto M; Xu B; Shi M; Matsuyama T; Aoyama K; Takeuchi T
    J Interferon Cytokine Res; 2007 Nov; 27(11):901-10. PubMed ID: 18052724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung.
    Santulli-Marotto S; Boakye K; Lacy E; Wu SJ; Luongo J; Kavalkovich K; Coelho A; Hogaboam CM; Ryan M
    PLoS One; 2013; 8(12):e81465. PubMed ID: 24339934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that phospholipase-C-dependent, calcium-independent mechanisms are required for directional migration of T-lymphocytes in response to the CCR4 ligands CCL17 and CCL22.
    Cronshaw DG; Kouroumalis A; Parry R; Webb A; Brown Z; Ward SG
    J Leukoc Biol; 2006 Jun; 79(6):1369-80. PubMed ID: 16614259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor.
    Bonecchi R; Locati M; Galliera E; Vulcano M; Sironi M; Fra AM; Gobbi M; Vecchi A; Sozzani S; Haribabu B; Van Damme J; Mantovani A
    J Immunol; 2004 Apr; 172(8):4972-6. PubMed ID: 15067078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis.
    Yogo Y; Fujishima S; Inoue T; Saito F; Shiomi T; Yamaguchi K; Ishizaka A
    Respir Res; 2009 Aug; 10(1):80. PubMed ID: 19715610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.
    Scheu S; Ali S; Ruland C; Arolt V; Alferink J
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.
    Kumai T; Nagato T; Kobayashi H; Komabayashi Y; Ueda S; Kishibe K; Ohkuri T; Takahara M; Celis E; Harabuchi Y
    Cancer Immunol Immunother; 2015 Jun; 64(6):697-705. PubMed ID: 25754123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells.
    Mariani M; Lang R; Binda E; Panina-Bordignon P; D'Ambrosio D
    Eur J Immunol; 2004 Jan; 34(1):231-40. PubMed ID: 14971049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation.
    Perros F; Hoogsteden HC; Coyle AJ; Lambrecht BN; Hammad H
    Allergy; 2009 Jul; 64(7):995-1002. PubMed ID: 19630858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.
    Di Stasi A; De Angelis B; Rooney CM; Zhang L; Mahendravada A; Foster AE; Heslop HE; Brenner MK; Dotti G; Savoldo B
    Blood; 2009 Jun; 113(25):6392-402. PubMed ID: 19377047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A degradatory fate for CCR4 suggests a primary role in Th2 inflammation.
    Anderson CA; Patel P; Viney JM; Phillips RM; Solari R; Pease JE
    J Leukoc Biol; 2020 Mar; 107(3):455-466. PubMed ID: 32052476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL17 and CCL22 induce CCR4 receptor expression and promote cytokine-induced killer cells migration.
    Dong Y; Gao S; Zhang X; Kou J; Liu J; Ye T; Shen H
    Anticancer Drugs; 2022 Feb; 33(2):149-157. PubMed ID: 34657098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4.
    Imai T; Chantry D; Raport CJ; Wood CL; Nishimura M; Godiska R; Yoshie O; Gray PW
    J Biol Chem; 1998 Jan; 273(3):1764-8. PubMed ID: 9430724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists.
    Ajram L; Begg M; Slack R; Cryan J; Hall D; Hodgson S; Ford A; Barnes A; Swieboda D; Mousnier A; Solari R
    Eur J Pharmacol; 2014 Apr; 729(100):75-85. PubMed ID: 24534492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309.
    Inngjerdingen M; Damaj B; Maghazachi AA
    J Immunol; 2000 Apr; 164(8):4048-54. PubMed ID: 10754297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the Th2 CC chemokine ligand CCL17 in pulmonary fibrosis.
    Belperio JA; Dy M; Murray L; Burdick MD; Xue YY; Strieter RM; Keane MP
    J Immunol; 2004 Oct; 173(7):4692-8. PubMed ID: 15383605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination.
    Bayry J; Tchilian EZ; Davies MN; Forbes EK; Draper SJ; Kaveri SV; Hill AV; Kazatchkine MD; Beverley PC; Flower DR; Tough DF
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10221-6. PubMed ID: 18621704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.